Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00966693 · COMPLETED
Trial details
- NCT number
- NCT00966693
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-25
- Primary completion
- 2018-07-20
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.